SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-296726
Filing Date
2020-11-18
Accepted
2020-11-18 12:31:28
Documents
3
Period of Report
2020-11-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d40728d8k.htm 8-K 18713
2 EX-99.1 d40728dex991.htm EX-99.1 12657
3 GRAPHIC g40728g1118120228810.jpg GRAPHIC 5362
  Complete submission text file 0001193125-20-296726.txt   40022
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 201323669
SIC: 2834 Pharmaceutical Preparations